Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
03/2003
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003US20030055239 Human receptor tyrosine kinase, KDR
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054494 Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
03/20/2003US20030054448 T1R taste receptors and genes encoding same
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053994 Genetic engineering; desroying infections; antitumor, anticancer agents
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/19/2003EP1293513A2 A recombinant human factor VIII derivative
03/19/2003EP1292830A2 Method for identifying insulin mimics or antagonists
03/19/2003EP1292827A1 T2r taste receptors and genes encoding same
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292695A2 Gene-regulating conjugates
03/19/2003EP1292681A1 Antigenic polypeptides
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292613A2 Chimeric gfp-aequorin as bioluminescent ca?++ reporters at the single cell level
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1403484A Prepn and application of transmembrane staphylococcus aureus toxin A fusion protein
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534288 Precursor of human insulin or insulin analog consisting of optional fusion portion, B chain of human insulin linked by amino acid chain to A chain of human insulin, in which chains can be modified with activity being preserved
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021265A1 Genetic construct intracellular monitoring system
03/13/2003WO2003020938A2 Method of protein production in plants
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020756A2 Hybrid and tandem expression of neisserial proteins
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030050469 Induction of a Th1-like response in vitro
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030049845 Viral envelope protein for use as tools gene therapy
03/13/2003US20030049842 Nucleotide sequences coding polypeptide for use in gene therapy and treatment of viral diseases
03/13/2003US20030049831 Protein for use in the prevention of infections
03/13/2003US20030049799 Chimeric protein for use in the treatment of autoimmune diseases
03/13/2003US20030049797 Hybrid proteins for autoimmune disease
03/13/2003US20030049694 Production of fusion proteins and use for identifying binding molecules
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049264 Releasing neurotransmitters; analgesics
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003CA2459816A1 Hybrid and tandem expression of neisserial proteins
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2458879A1 Genetic construct intracellular monitoring system
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1290230A2 Hepatitis c virus conjugates
03/12/2003EP1290197A2 Leader peptides for enhancing secretion of recombinant protein from a host cell
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290175A1 Scramblase 2
03/12/2003EP1290173A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwk1)
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP0781095B1 Cells bearing cd4 decoy receptors and related molecules and methods
03/12/2003CN1401776A Construction and expression of recombinant human B cell stimulating factor (rhBLyS) expression vector, and monoclonal antibody preparation and use
03/12/2003CN1401662A Anticoagulation and thrombolytic thrombus target fusion mA5UKB
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531138 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypetides and peptides in the diagnostic of tuberculosis
03/11/2003US6531134 Mammalian milk growth factor
03/11/2003US6531133 Pseudomonas exotoxin-myelin basic protein chimeric proteins
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018044A1 New drug
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002081683A3 Protein analysis by means of immobilized arrays of antigens or antibodies
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 295